Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization.
about
ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomasExpression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma.Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation StatusMolecular profile of oligodendrogliomas in young patientsCDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.C-MET overexpression and amplification in gliomasAnalysis of the BRAF(V600E) Mutation in Central Nervous System Tumors.Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study.A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.Methylation Status of the O6-Methylguanine-Deoxyribonucleic Acid Methyltransferase Gene Promoter in World Health Organization Grade III Gliomas.Clinicopathological and genetic characteristics of extraventricular neurocytomas.p14ARF promoter region methylation as a marker for gliomas diagnosis.TP53 mutations in canine brain tumors.Oligodendroglioma (WHO grade I) in a young epilepsy patient: a specific entity lying within the spectrum of dysembryoplastic neuroepithelial tumor?Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
P2860
Q33784207-DDF1D42F-622D-49C7-B3BE-A9E226B37FB9Q33917659-F9E95EE2-4231-4F79-962C-8944EB1D965AQ35028828-A55DAADD-8E15-441B-A240-953FDF087175Q35225293-D58F2BA2-ADB7-40D2-9A28-8422517E9092Q35418206-FCE559AC-5DF0-4424-B530-89C19CC64DE1Q35633835-F8C8B544-489B-4F87-99D1-2EE7616D852CQ35681251-A836EA82-B08C-473F-972D-01C90C8E7FFBQ36464716-B69BA13D-F417-433F-9779-4826BD090491Q36525778-ED587681-221A-4D84-B591-07B2A6F3BAD4Q36696480-60E7BF20-824D-44C5-BD03-72EF44BA328EQ36919406-892B056F-6E29-4D9A-B219-EE51B2729050Q37412104-7164F2F0-3B9A-480F-9C1A-5224C8D01E3EQ38016599-721DF914-CBF9-4B45-B9D3-F51276771508Q45358556-F1222042-7553-4907-8302-DB2D5D310497Q46179627-7E63F665-5738-4955-A0FB-AF07EB1DA1C6Q48152984-ADF9924E-F73B-42E9-A2F2-74AF8EF91CD7Q54123926-91D9E26E-AA2E-4945-B6D5-404BFD7F1851Q55461118-13506BDE-E29E-497F-8A25-FB6D89D7E3AE
P2860
Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@en
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@nl
type
label
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@en
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@nl
prefLabel
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@en
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@nl
P2093
P2860
P1433
P1476
Chromosome 1p and 19q status a ...... escence in situ hybridization.
@en
P2093
Chul Ki Park
Hee Won Jung
Kyeongmee Park
Sun Ha Paek
Sung-Hye Park
Yoon Kyung Jeon
P2860
P356
10.1111/J.1440-1789.2006.00735.X
P577
2007-02-01T00:00:00Z